Risk Factors and Outcomes Analyses at 36 Months of a Prospective, Randomized, Multicenter, Trial of Daclizumab Induction in Simultaneous Kidney–Pancreas Transplant Recipients
Year: 2005
Type: article
Source: Transplantation Proceedings
Authors: R.J. Stratta, R.R. Alloway, A. Lo, E.E. Hodge
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1973869431
